InvestorsHub Logo
icon url

DonDonDonDon

06/04/21 3:49 PM

#169095 RE: stockorus #169093

Wait. I have to recheck the topline results, did not know they have now replaced 24 with 31.


Yep, it is clearly data manipulation. So I'm working on the assumption that they are manipulating the 7 and 14 day efficacy the same way they are manipulating the 28 day efficacy.

7 days --78%
14 days --82%
21 days --50%
28 days --31%.
icon url

misiu143

06/04/21 4:23 PM

#169101 RE: stockorus #169093

Stockorus.., Yes they explained at one of the CC that as the data was clean better , mortality at 28 days , improved from 24 to 31% above SOC drugs.

So even with these restriction of treatment to 2 weeks , without ANY REASONABLE explanation ,
Still 31% less patients will die with leronlimab then without..

This mean in every 100 people who died , 31 will live if given leronlimab.
And this is with 2 weeks treatment , lets see how many more lives will be saved with 4 weeks treatment..

Yes this is US medical care during this pandemic ..it is really scary ..

I am sure when within months leronlimab will be use and saving lives in many countries around the world , but not USA ,
in 1 , or 2 , or 3 years , American media may notice that and start to question.


GLTA longs.

All IMO.